Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT04699838 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04699838
- Sponsor
- Muhammad Furqan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2026-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.